Literature DB >> 5373

Biological properties of an immunogenic pneumococcal subcellular preparation.

H C Thompson, T K Eisenstein.   

Abstract

A subcellular fraction, designated PSP-3R, prepared from rough, type 3R Streptococcus pneumoniae is described, which affords excellent protection to mice against challenge with smooth organisms of the homologous serotype 3S and significant protection against heterologous challenge with serotypes 1S and 2S. Adjuvant enhances the protective capacity of the vaccine but is not necessary for immunogenicity. Protection induced by PSP-3R can be passively transferred tp normal mice with serum from actively immunized animals. The protective capacity can be completely absorbed out with rough or smooth type 3 organisms but not with rough type 1R or 2R cells. PSP-3R immune serum was tested in a passive hemagglutination assay against type 3 capsular polysaccharide-coated erythrocytes and found to have no detectable anticapsular antibody. The possible identity of the immunogen (s) in the vaccine is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5373      PMCID: PMC420673          DOI: 10.1128/iai.13.3.750-757.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  The culture of Streptococcus pneumoniae.

Authors:  L B HOLT
Journal:  J Gen Microbiol       Date:  1962-02

2.  The use of spiral loops in serological and virological micro-methods.

Authors:  G TAKATSY
Journal:  Acta Microbiol Acad Sci Hung       Date:  1955

Review 3.  Teichoic acids in cell walls and membranes of bacteria.

Authors:  J Baddiley
Journal:  Essays Biochem       Date:  1972       Impact factor: 8.000

4.  The ills of man.

Authors:  J H Dingle
Journal:  Sci Am       Date:  1973-09       Impact factor: 2.142

Review 5.  Lipoteichoic acids: a new class of bacterial antigen.

Authors:  A J Wicken; K W Knox
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

6.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

8.  Protection against pneumococcal infection by a ribosomal preparation.

Authors:  H C Thompson; I S Snyder
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

  8 in total
  17 in total

1.  Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains.

Authors:  Marina Eyngor; Yoram Tekoah; Roni Shapira; Avshalom Hurvitz; Amir Zlotkin; Avishay Lublin; Avi Eldar
Journal:  Appl Environ Microbiol       Date:  2008-09-19       Impact factor: 4.792

2.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

3.  Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.

Authors:  R P Tewari; M Lynn; A J Birnbaum; M Solotorovsky
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Immunoprotective activity of ribosomes from Haemophilus influenzae.

Authors:  M Lynn; R P Tewari; M Solotorovsky
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

6.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

7.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

Authors:  B M Gray; H C Dillon; D E Briles
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

9.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

Authors:  E J Brown; S W Hosea; C H Hammer; C G Burch; M M Frank
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.